Combination of umbilical cord mesenchymal stem cells and standard immunosuppressive regimen for pediatric patients with severe aplastic anemia
Abstract Background Defects of bone marrow mesenchymal stem cells (BM-MSCs) in proliferation and differentiation are involved in the pathophysiology of aplastic anemia (AA). Infusion of umbilical cord mesenchymal stem cells (UC-MSCs) may improve the efficacy of immunosuppressive therapy (IST) in chi...
Main Authors: | Yang Lan, Fang Liu, Lixian Chang, Lipeng Liu, Yingchi Zhang, Meihui Yi, Yuli Cai, Jing Feng, Zhibo Han, Zhongchao Han, Xiaofan Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | BMC Pediatrics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12887-021-02562-x |
Similar Items
Current management of severe acquired aplastic anemia
by: Phillip Scheinberg
Published: (2011-06-01)
by: Phillip Scheinberg
Published: (2011-06-01)
Current management of severe acquired aplastic anemia
by: Phillip Scheinberg
Published: (2011-06-01)
by: Phillip Scheinberg
Published: (2011-06-01)
Similar Items
-
Immunosuppressive Treatment in Children with Acquired Aplastic Anemia
by: Yıldız Yıldırmak, et al.
Published: (2012-05-01) -
Comparison of intensive immunosuppressive therapy with haploidentical transplantation for young severe aplastic anemia
by: CHEN Miao, WU Ya-mei, ZHOU Dao-bin, DUAN Ming-hui, ZHUANG Jun-ling, HAN Bing, WU Xiao-xiong
Published: (2020-06-01) -
Umbilical cord-derived mesenchymal stem cells cultured in the MCL medium for aplastic anemia therapy
by: Chuan He, et al.
Published: (2023-08-01) -
APLASTIC ANEMIA
by: Ni Made Dharma Laksmi, et al.
Published: (2013-07-01) -
Feasibility and effectiveness of the prolonged use of eltrombopag in addition to immunosuppression in patients with acquired aplastic anemia: a single-center real-life experience
by: Monica Carpenedo, et al.
Published: (2024-12-01)